NASDAQ · STOCK
Cardinal Health
$232.69
52W $137.75 – $243.21
58/100
$55.54B
36.0
0.53
Price History (6M)
Executive Summary
6 analysts weighed in with 50% agreement on a bullish lean. Growth Analyst: 4 consecutive earnings beats -- consistent execution. Risk Analyst: High leverage (debt-to-equity 3.48) amplifies downside in a stress scenario. Overall recommendation: WATCH.
Executive Summary
6 analysts weighed in with 50% agreement on a bullish lean. Growth Analyst: 4 consecutive earnings beats -- consistent execution. Risk Analyst: High leverage (debt-to-equity 3.48) amplifies downside in a stress scenario. Overall recommendation: WATCH.
Bull & Bear Case
Bull Case
- Daily trend: uptrend.
- Weekly trend: uptrend.
- Daily and weekly trends are both bullish — multi-timeframe alignment, highest confidence.
- Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
- MACD histogram is negative (-0.011) — bearish momentum.
- Lower Highs / Lower Lows structure confirms bearish price action.
- Fundamental score is weak (29.9/100) — poor financial health or expensive valuation.
AI Investment Committee
Committee Consensus
As of July 07, 2026
Overall Committee Score
58/100
Agreement
50%
Analysts
6
Conviction
Contested
Value Analyst
neutral
45
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 37.2% shows genuine earnings power backing the valuation
− P/E of 36.0 is moderate-to-rich
Growth Analyst
bullish
77
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ 4 consecutive earnings beats -- consistent execution
Technical Analyst
neutral
57
/ 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Risk Analyst
bearish
32
/ 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 3.48) amplifies downside in a stress scenario
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
62
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Technical Analysis
RSI (14)
65.4
Neutral
MACD Histogram
-0.011
Bearish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Lh Ll
Bollinger %B
0.72
Inside Bands
Price vs Moving Averages
EMA 9
$235.99
Below
EMA 21
$228.41
Above
EMA 50
$218.08
Above
EMA 200
$199.90
Above
Fundamental Analysis
Valuation
8
Growth
73
Profitability
33
Financial Health
6
Valuation
P/E Ratio
36.0×
P/B Ratio
9.25×
PEG Ratio
—
Dividend Yield
0.85%
52W High
$243.21
52W Low
$137.75
Quality & Growth
ROE
3717.0%
ROA
279.0%
Gross Margin
376.0%
Operating Margin
92.0%
Revenue Growth YoY
+1288.0%
Debt / Equity
3.48
AI Fundamental Assessment
P/E ratio of 36.0 (rich relative to a 15-40x range); Price-to-book of 9.2x; Revenue growth (YoY) of 12.9%; EPS growth (YoY) of 2.3%; Return on equity of 37.2%; Return on assets of 2.8%; Net margin of 0.6%; Gross margin of 3.8%; Current ratio of 0.94 (tight short-term liquidity); Debt-to-equity of 3.48; Most recent quarter beat estimates by 12.6%; 4 consecutive earnings beats; EPS growth accelerating (+3.1% -> +20.5% QoQ); Analyst estimates rising over recent quarters
Key Risks
- MACD histogram is negative (-0.011) — bearish momentum.
- Lower Highs / Lower Lows structure confirms bearish price action.
- Fundamental score is weak (29.9/100) — poor financial health or expensive valuation.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full CAH Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Mobile